Case #, gender, age(years) | Location of lesion | AO (approx. %) | TEA nd/dd (mg) | EBB (n) | Histology |
---|---|---|---|---|---|
Necrotic tumor (n = 8) | |||||
1 M(73) | RMB | 80 | 250/120 | 10 | SqCC |
2 M(41) | RMB | 90 | 250/120 | 5 | SqCC |
3 M(66) | RB3 | 100 | 250/120 | 3 | SqCC |
4 M(64) | RLLB | 100 | 500/370 | 6 | SqCC |
5 M(72) | RBB | 100 | 500/370 | 3 | SqCC |
6 M(58) | RULB | 100 | 500/370 | 6 | SqCC |
7 M(64) | RULB | 90 | 500/370 | 5 | AC |
8 M(80)* | LMB | 100 | 500/370 | 5 | MMT |
Hypervascular tumor (n = 12) | |||||
9 M(79) | RBI | 70 | 250/120 | 4 | SqCC |
10 M(58)* | RMLB | 90 | 250/120 | 3 | SCLC |
11 M(53) | LULB | 100 | 500/370 | 4 | SqCC |
12 M(61) | LB4 | 80 | 500/370 | 5 | SCLC |
13 M(47) | RMB | 90 | 500/370 | 6 | SqCC |
14 M(50) | LULB | 50 | 500/370 | 7 | AC |
15 M(62) | RMB | 90 | 500/370 | 9 | SqCC |
16 M(60) | Trachea-LMB | 50-80 | 500/370 | 6 | SqCC |
17 M(59) | LULB | 80 | 500/370 | 6 | SCLC |
18 M(64) | RULB | 100 | 500/370 | 6 | SqCC |
19 M(53) | LULB | 50 | 500/370 | 7 | SqCC |
20 M(67) | RBI | 60 | 500/370 | 7 | SqCC |